Perioperative pirfenidone treatment as prophylaxis against acute exacerbation of idiopathic pulmonary fibrosis: a single-center analysis
ConclusionsAlthough perioperative pirfenidone treatment did not obviously prevent postoperative AE-IPF, it may reduce the mortality of lung cancer patients with IPF.
Source: Surgery Today - Category: Surgery Source Type: research
More News: Cancer | Cancer & Oncology | Lung Cancer | Respiratory Medicine | Smokers | Study | Surgery